Literature DB >> 17671643

Prime suspect: the TCF7L2 gene and type 2 diabetes risk.

Andrew T Hattersley1.   

Abstract

Transcription factor-7-like 2 (TCF7L2) is the most important type 2 diabetes susceptibility gene identified to date, with common intronic variants strongly associated with diabetes in all major racial groups. This ubiquitous transcription factor in the Wnt signaling pathway was not previously known to be involved in glucose homeostasis, so defining the underlying mechanism(s) will provide new insights into diabetes. In this issue of the JCI, Lyssenko and colleagues report on their human and isolated islet studies and suggest that the risk allele increases TCF7L2 expression in the pancreatic beta cell, reducing insulin secretion and hence predisposing the individual to diabetes (see the related article beginning on page 2155).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17671643      PMCID: PMC1934573          DOI: 10.1172/JCI33077

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility.

Authors:  Michael N Weedon; Peter E H Schwarz; Yukio Horikawa; Naoko Iwasaki; Thomas Illig; Rolf Holle; Wolfgang Rathmann; Thomas Selisko; Jan Schulze; Katherine R Owen; Julie Evans; Laura Del Bosque-Plata; Graham Hitman; Mark Walker; Jonathan C Levy; Mike Sampson; Graeme I Bell; Mark I McCarthy; Andrew T Hattersley; Timothy M Frayling
Journal:  Am J Hum Genet       Date:  2003-11       Impact factor: 11.025

2.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.

Authors:  Struan F A Grant; Gudmar Thorleifsson; Inga Reynisdottir; Rafn Benediktsson; Andrei Manolescu; Jesus Sainz; Agnar Helgason; Hreinn Stefansson; Valur Emilsson; Anna Helgadottir; Unnur Styrkarsdottir; Kristinn P Magnusson; G Bragi Walters; Ebba Palsdottir; Thorbjorg Jonsdottir; Thorunn Gudmundsdottir; Arnaldur Gylfason; Jona Saemundsdottir; Robert L Wilensky; Muredach P Reilly; Daniel J Rader; Yu Bagger; Claus Christiansen; Vilmundur Gudnason; Gunnar Sigurdsson; Unnur Thorsteinsdottir; Jeffrey R Gulcher; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2006-01-15       Impact factor: 38.330

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

4.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

Authors:  D Altshuler; J N Hirschhorn; M Klannemark; C M Lindgren; M C Vohl; J Nemesh; C R Lane; S F Schaffner; S Bolk; C Brewer; T Tuomi; D Gaudet; T J Hudson; M Daly; L Groop; E S Lander
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

5.  TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.

Authors:  Jose C Florez; Kathleen A Jablonski; Nick Bayley; Toni I Pollin; Paul I W de Bakker; Alan R Shuldiner; William C Knowler; David M Nathan; David Altshuler
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

6.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.

Authors:  Y Horikawa; N Oda; N J Cox; X Li; M Orho-Melander; M Hara; Y Hinokio; T H Lindner; H Mashima; P E Schwarz; L del Bosque-Plata; Y Horikawa; Y Oda; I Yoshiuchi; S Colilla; K S Polonsky; S Wei; P Concannon; N Iwasaki; J Schulze; L J Baier; C Bogardus; L Groop; E Boerwinkle; C L Hanis; G I Bell
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

7.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

8.  Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.

Authors:  Anna L Gloyn; Michael N Weedon; Katharine R Owen; Martina J Turner; Bridget A Knight; Graham Hitman; Mark Walker; Jonathan C Levy; Mike Sampson; Stephanie Halford; Mark I McCarthy; Andrew T Hattersley; Timothy M Frayling
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

9.  RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets.

Authors:  James D Johnson; Zhiqiang Han; Kenichi Otani; Honggang Ye; Yan Zhang; Hong Wu; Yukio Horikawa; Stanley Misler; Graeme I Bell; Kenneth S Polonsky
Journal:  J Biol Chem       Date:  2004-03-25       Impact factor: 5.157

10.  TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.

Authors:  Ruth J F Loos; Paul W Franks; Richard W Francis; Inês Barroso; Fiona M Gribble; David B Savage; Ken K Ong; Stephen O'Rahilly; Nicholas J Wareham
Journal:  Diabetes       Date:  2007-04-06       Impact factor: 9.461

View more
  19 in total

1.  Wnt signaling regulates hepatic metabolism.

Authors:  Hongjun Liu; Maria M Fergusson; J Julie Wu; Ilsa I Rovira; Jie Liu; Oksana Gavrilova; Teng Lu; Jianjun Bao; Donghe Han; Michael N Sack; Toren Finkel
Journal:  Sci Signal       Date:  2011-02-01       Impact factor: 8.192

2.  Sideways Glance: Genome wide association studies for type 2 diabetes mellitus.

Authors:  Yula Sambuy
Journal:  Genes Nutr       Date:  2007-12       Impact factor: 5.523

3.  Personalized medicine for diabetes.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2008-05

4.  Expression of the diabetes-associated gene TCF7L2 in adult mouse brain.

Authors:  Syann Lee; Charlotte E Lee; Carol F Elias; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2009-12-20       Impact factor: 3.215

Review 5.  Liver zonation: Novel aspects of its regulation and its impact on homeostasis.

Authors:  Rolf Gebhardt; Madlen Matz-Soja
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 6.  Overlap of genetic susceptibility to type 1 diabetes, type 2 diabetes, and latent autoimmune diabetes in adults.

Authors:  Kevin J Basile; Vanessa C Guy; Stanley Schwartz; Struan F A Grant
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

7.  Generation of high quality chromatin immunoprecipitation DNA template for high-throughput sequencing (ChIP-seq).

Authors:  Sandra Deliard; Jianhua Zhao; Qianghua Xia; Struan F A Grant
Journal:  J Vis Exp       Date:  2013-04-19       Impact factor: 1.355

Review 8.  Pharmacogenetic studies update in type 2 diabetes mellitus.

Authors:  Shalini Singh; Kauser Usman; Monisha Banerjee
Journal:  World J Diabetes       Date:  2016-08-10

Review 9.  TNF-alpha and adipocyte biology.

Authors:  William P Cawthorn; Jaswinder K Sethi
Journal:  FEBS Lett       Date:  2007-11-26       Impact factor: 4.124

Review 10.  Pharmacogenetics of glucose-lowering drug treatment: a systematic review.

Authors:  Ozlem Bozkurt; Anthonius de Boer; Diederick E Grobbee; Eibert R Heerdink; Huib Burger; Olaf H Klungel
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.